100
Participants
Start Date
February 29, 2004
Study Completion Date
July 31, 2006
docetaxel
PI-88
Prince of Wales Hospital, Randwick
Sydney Cancer Centre, Royal Prince Alfred Hospital, Camperdown
Royal North Shore Hospital, St Leonards
Sydney Haematology and Oncology Clinics, Hornsby
Newcastle Mater Misericordiae Hospital, Waratah
The Alfred Hospital, Prahran
Border Medical Oncology, Wodonga
Prince Charles Hospital, Chermside
Mater Hospital, South Brisbane
Princess Alexandra Hospital, Woolloongabba
Nambour General Hospital, Nambour
The Queen Elizabeth Hospital, Woodville
Sir Charles Gairdner Hospital, Nedlands
Lead Sponsor
Collaborators (1)
Medigen Biotechnology Corporation
INDUSTRY
Cellxpert Biotechnology Corp.
INDUSTRY